Welcome!

News Feed Item

Plandai Biotechnology Management Discusses Progress of Company's Cannabis Extracts

NEW YORK, NY -- (Marketwired) -- 03/28/14 -- Last month Plandaí Biotechnology, Inc. (OTCQB: PLPL) closed a licensing agreement with Diego Pellicer, Inc. that will allow the company to use the Diego Pellicer name for its Phytofare™ cannabis extract in medical and pharmaceutical marijuana applications. Plandaí will produce the new Diego Pellicer Gold™ extracts in both capsules and cannabis oil (for vapor use) in Pheroid™ and non-Pheroid™ versions to appeal to the broadest range of medicinal consumers.

Stock Market Media Group (SMMG), a full service research and content development investor relations firm, asked Plandaí's management about the company's journey to introduce cannabis extracts to the market.

SMMG: Where is Plandai in the process of adding cannabis products?

Plandaí: "We are doing several things simultaneously. First, we're reviewing the various strains of cannabis and selecting one that we feel will have the best chemical profile for what we want to accomplish with the extract.

We're also working in Washington to ensure that we have live plant matter available for testing later in the year. Finally, we are engineering a CRS hydrodynamic processing and extraction system and constructing a laboratory in Washington that will make the initial extract for testing."

SMMG: What has been completed in the process and what is left to complete?

Plandaí: "The initial steps involved determining if we could even make a cannabis extract. This involved a review of the legal environment, the physical properties of the plant, and the chemical properties of the plant. We then needed to hire a small team that could 1) Select the correct strain, 2) Establish cultivation protocols, 3) Reach out to investigational institutions to begin lining up clinical trials, and 4) Adapt our current extraction system to be able to process cannabis. All of these things have happened.

We expect to finalize terms with a cultivation facility in the coming weeks so that we have suitable established plants in adequate quantities by this fall to begin making sample extract. Remember, we must use live plant material and we must use a specific and reproducible strain. We can't just go into a shop and buy dry leaf. Working with local growers, we need to document their cultivation techniques, fertilizer, etc. All of these things can impact the chemical profile. So, we need to manage the process to ensure that we have the correct chemical profile.

Concurrently, we will be building a small-scale lab so that we can produce our first cannabinoid extract. This will then need to be tested to get a chemical profile. We then need to test it for bioavailability and establish dosage parameters. Only then can we start testing for specific medical properties and benefits."

SMMG: What role will both the hydrodynamic sheering process and Pheroid® play in the production of extracts?

Plandaí: "The hydrodynamic sheering process is what breaks down and separates the plant structures, giving us increased bioavailability as well as allowing us to maximize the amount of phytonutrients we extract. All of our products will go through this process. The specific processing challenges we face with cannabis are releasing THC and CBD from the viscous cannabis oil and in the process reducing the articles to a high percentage of nano from the current ratio of 250-350mg. To achieve this, new formulated liquids will be used in the processing cycle.

The Pheroid® brings in certain additional properties which, depending on the individual may be considered advantageous or disadvantageous.

Essentially, the Pheroid® will entrap the cannabinoids until they reach the cells. This means that the THC will not metabolize in the blood stream, thus conceivably eliminating the psychoactive effects. We believe that we will be able to deliver a meaningful dosage of cannabinoids without the accompanying 'high.'

This will be ideal for patients with neural disorders and diseases. Some conditions require or prefer the metabolized THC and welcome the associated psychoactive effects. Thus, we expect to develop and test both a Pheroid® and non-Pheroid® version of the product."

SMMG: Where will these extracts be sold?

Plandaí: "We do not plan on having retail locations or selling directly to consumers. We are an ingredient manufacturer for nutraceutical and pharmaceutical applications. We will produce our extracts and then look to sell them to manufacturers of finished goods or into medicinal applications."

SMMG: What role, if any, will your South African plantation and manufacturing facility play in the future of your cannabis extract?

Plandaí: "Presently, South African law prohibits the cultivation of cannabis and furthermore it would be impossible to legally export or import any cannabis-based products or extracts. Our South Africa estate and factory is set up exclusively for processing our Phytofare™ Catechin Complex, which is made from green tea, though eventually we expect to also produce a citrus complex at this same facility. So, our South Africa operations will not be involved in any way for the foreseeable future. Until we are through with our research and animal trials, it is premature to speculate on when, if, or where we will produce a commercial cannabis extract, but we will only be involved if we can be assured that we are complying with all Federal and state laws.

As we recently announced, however, an appeal was made on our behalf to the South African legislature to grant Plandaí a special dispensation, or waiver, allowing us to produce and test a cannabinoid Phytofare™ extract for human clinical trials. In addition, legislation has recently been introduced in South Africa to permit medical marijuana research. Should this legislation pass, or should the government grant us special dispensation, it could open up the door to advancing medical research on an accelerated basis. We will know more in the coming months and will keep our shareholders apprised of any developments on this front."

About Stock Market Media Group

SMMG is a full service IR firm specializing in Research and Content Development. It offers a platform for corporate stories to unfold through the media with Reports, Interviews and Articles. SMMG is compensated for Plandaí articles, reports and interviews by a third party who reserves the right to sell securities at any time before, during, or after the publication of this article. To date, SMMG has received total compensation of $36,290, for content related to Plandaí. For more information and to read full disclaimers and disclosures: www.stockmarketmediagroup.com/disclaimer.

Add to Digg Bookmark with del.icio.us Add to Newsvine

Contact:
Stock Market Media Group
Email Contact

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest Stories
Digital transformation has increased the pace of business creating a productivity divide between the technology haves and have nots. Managing financial information on spreadsheets and piecing together insight from numerous disconnected systems is no longer an option. Rapid market changes and aggressive competition are motivating business leaders to reevaluate legacy technology investments in search of modern technologies to achieve greater agility, reduced costs and organizational efficiencies. ...
Amazon started as an online bookseller 20 years ago. Since then, it has evolved into a technology juggernaut that has disrupted multiple markets and industries and touches many aspects of our lives. It is a relentless technology and business model innovator driving disruption throughout numerous ecosystems. Amazon’s AWS revenues alone are approaching $16B a year making it one of the largest IT companies in the world. With dominant offerings in Cloud, IoT, eCommerce, Big Data, AI, Digital Assista...
The taxi industry never saw Uber coming. Startups are a threat to incumbents like never before, and a major enabler for startups is that they are instantly “cloud ready.” If innovation moves at the pace of IT, then your company is in trouble. Why? Because your data center will not keep up with frenetic pace AWS, Microsoft and Google are rolling out new capabilities. In his session at 20th Cloud Expo, Don Browning, VP of Cloud Architecture at Turner, posited that disruption is inevitable for comp...
Organizations planning enterprise data center consolidation and modernization projects are faced with a challenging, costly reality. Requirements to deploy modern, cloud-native applications simultaneously with traditional client/server applications are almost impossible to achieve with hardware-centric enterprise infrastructure. Compute and network infrastructure are fast moving down a software-defined path, but storage has been a laggard. Until now.
When you focus on a journey from up-close, you look at your own technical and cultural history and how you changed it for the benefit of the customer. This was our starting point: too many integration issues, 13 SWP days and very long cycles. It was evident that in this fast-paced industry we could no longer afford this reality. We needed something that would take us beyond reducing the development lifecycles, CI and Agile methodologies. We made a fundamental difference, even changed our culture...
High-velocity engineering teams are applying not only continuous delivery processes, but also lessons in experimentation from established leaders like Amazon, Netflix, and Facebook. These companies have made experimentation a foundation for their release processes, allowing them to try out major feature releases and redesigns within smaller groups before making them broadly available. In his session at 21st Cloud Expo, Brian Lucas, Senior Staff Engineer at Optimizely, discussed how by using ne...
In his session at 20th Cloud Expo, Mike Johnston, an infrastructure engineer at Supergiant.io, discussed how to use Kubernetes to set up a SaaS infrastructure for your business. Mike Johnston is an infrastructure engineer at Supergiant.io with over 12 years of experience designing, deploying, and maintaining server and workstation infrastructure at all scales. He has experience with brick and mortar data centers as well as cloud providers like Digital Ocean, Amazon Web Services, and Rackspace. H...
Without a clear strategy for cost control and an architecture designed with cloud services in mind, costs and operational performance can quickly get out of control. To avoid multiple architectural redesigns requires extensive thought and planning. Boundary (now part of BMC) launched a new public-facing multi-tenant high resolution monitoring service on Amazon AWS two years ago, facing challenges and learning best practices in the early days of the new service.
@DevOpsSummit New York 2018, colocated with CloudEXPO | DXWorldEXPO New York 2018 will be held November 11-13, 2018, in New York City. From showcase success stories from early adopters and web-scale businesses, DevOps is expanding to organizations of all sizes, including the world's largest enterprises - and delivering real results.
In his general session at 19th Cloud Expo, Manish Dixit, VP of Product and Engineering at Dice, discussed how Dice leverages data insights and tools to help both tech professionals and recruiters better understand how skills relate to each other and which skills are in high demand using interactive visualizations and salary indicator tools to maximize earning potential. Manish Dixit is VP of Product and Engineering at Dice. As the leader of the Product, Engineering and Data Sciences team at D...
Digital Transformation is much more than a buzzword. The radical shift to digital mechanisms for almost every process is evident across all industries and verticals. This is often especially true in financial services, where the legacy environment is many times unable to keep up with the rapidly shifting demands of the consumer. The constant pressure to provide complete, omnichannel delivery of customer-facing solutions to meet both regulatory and customer demands is putting enormous pressure on...
DXWorldEXPO LLC announced today that All in Mobile, a mobile app development company from Poland, will exhibit at the 22nd International CloudEXPO | DXWorldEXPO. All In Mobile is a mobile app development company from Poland. Since 2014, they maintain passion for developing mobile applications for enterprises and startups worldwide.
Both SaaS vendors and SaaS buyers are going “all-in” to hyperscale IaaS platforms such as AWS, which is disrupting the SaaS value proposition. Why should the enterprise SaaS consumer pay for the SaaS service if their data is resident in adjacent AWS S3 buckets? If both SaaS sellers and buyers are using the same cloud tools, automation and pay-per-transaction model offered by IaaS platforms, then why not host the “shrink-wrapped” software in the customers’ cloud? Further, serverless computing, cl...
With 10 simultaneous tracks, keynotes, general sessions and targeted breakout classes, @CloudEXPO and DXWorldEXPO are two of the most important technology events of the year. Since its launch over eight years ago, @CloudEXPO and DXWorldEXPO have presented a rock star faculty as well as showcased hundreds of sponsors and exhibitors!
"Akvelon is a software development company and we also provide consultancy services to folks who are looking to scale or accelerate their engineering roadmaps," explained Jeremiah Mothersell, Marketing Manager at Akvelon, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.